NPI: 1922376136 · SCRANTON, PA 18510 · General Acute Care Hospital · NPI assigned 12/02/2011
Authorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
| Authorized Official | LALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL) |
| NPI Enumeration Date | 12/02/2011 |
Other providers sharing the same authorized official: LALOR, PAULA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 143 | $13K |
| 2019 | 687 | $29K |
| 2020 | 27,131 | $608K |
| 2021 | 124,641 | $2.95M |
| 2022 | 41,497 | $1.06M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 10,300 | 9,677 | $899K |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 12,827 | 12,377 | $708K |
| G0378 | Hospital observation service, per hour | 321 | 306 | $328K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2,221 | 2,123 | $236K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 6,823 | 6,626 | $215K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 974 | 958 | $155K |
| 80053 | Comprehensive metabolic panel | 13,258 | 12,432 | $129K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4,476 | 4,223 | $112K |
| X0621 | 449 | 205 | $94K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1,003 | 959 | $75K |
| 70450 | Computed tomography, head or brain; without contrast material | 1,248 | 1,215 | $72K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 14,390 | 13,161 | $70K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 6,239 | 5,960 | $68K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 2,254 | 2,248 | $68K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1,146 | 1,080 | $60K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1,582 | 1,542 | $60K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 787 | 769 | $59K |
| 84443 | Thyroid stimulating hormone (TSH) | 2,822 | 2,759 | $56K |
| 76818 | 862 | 451 | $49K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,799 | 1,775 | $39K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2,376 | 2,201 | $38K |
| 96361 | Intravenous infusion, hydration; each additional hour | 3,329 | 3,065 | $36K |
| 80061 | Lipid panel | 2,433 | 2,400 | $30K |
| 71046 | Radiologic examination, chest; 2 views | 2,257 | 2,202 | $29K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 749 | 624 | $29K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3,332 | 3,060 | $27K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 502 | 436 | $26K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 127 | 123 | $26K |
| 76830 | Ultrasound, transvaginal | 607 | 593 | $26K |
| 81001 | 9,267 | 8,807 | $23K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 293 | 293 | $23K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1,038 | 1,015 | $22K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 638 | 632 | $22K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1,012 | 990 | $22K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 3,267 | 3,096 | $22K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 321 | 316 | $21K |
| 78815 | Positron emission tomography (PET) for limited area imaging | 28 | 26 | $20K |
| 80050 | General health panel | 488 | 485 | $19K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 783 | 752 | $19K |
| 71045 | Radiologic examination, chest; single view | 2,731 | 2,648 | $19K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 567 | 549 | $19K |
| 84702 | 1,176 | 896 | $19K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1,267 | 1,134 | $17K |
| 84484 | 2,177 | 1,941 | $16K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 49 | 47 | $16K |
| 72125 | Computed tomography, cervical spine; without contrast material | 245 | 237 | $15K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 531 | 527 | $14K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 280 | 279 | $14K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 793 | 769 | $14K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 471 | 414 | $14K |
| 86803 | 723 | 716 | $13K | |
| 76801 | 323 | 304 | $12K | |
| 84439 | 1,531 | 1,511 | $11K | |
| 83690 | 2,566 | 2,471 | $11K | |
| 76775 | 244 | 240 | $11K | |
| 85027 | 1,524 | 1,460 | $10K | |
| 93971 | 154 | 152 | $10K | |
| 84703 | 1,088 | 1,063 | $10K | |
| 86762 | 486 | 483 | $9K | |
| 76642 | 241 | 238 | $9K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 106 | 95 | $9K |
| 77066 | Tomosynthesis, mammo | 105 | 104 | $9K |
| 87040 | 858 | 557 | $8K | |
| 88342 | 217 | 205 | $8K | |
| 86850 | 1,088 | 1,005 | $8K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 251 | 251 | $8K |
| 83880 | 336 | 320 | $8K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1,281 | 1,259 | $8K |
| 84466 | 491 | 486 | $7K | |
| 87807 | 616 | 603 | $7K | |
| 87340 | 537 | 531 | $7K | |
| 82607 | 634 | 624 | $7K | |
| 83735 | 1,464 | 1,281 | $7K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 158 | 152 | $7K |
| 81025 | 2,222 | 2,119 | $7K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1,082 | 999 | $7K |
| 71250 | 141 | 137 | $7K | |
| 36415 | Collection of venous blood by venipuncture | 5,416 | 4,303 | $7K |
| 74018 | 494 | 477 | $6K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 293 | 293 | $6K |
| 85730 | 1,148 | 1,080 | $6K | |
| 85379 | 624 | 609 | $6K | |
| 76536 | 131 | 126 | $6K | |
| 73564 | 275 | 270 | $5K | |
| 82728 | 472 | 469 | $5K | |
| 86901 | 1,444 | 1,318 | $5K | |
| 86900 | 1,443 | 1,317 | $5K | |
| 84481 | 235 | 232 | $5K | |
| 73610 | 299 | 296 | $5K | |
| 85610 | 1,665 | 1,538 | $5K | |
| 72131 | 75 | 72 | $5K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 117 | 117 | $5K |
| 87077 | 382 | 357 | $4K | |
| 93970 | 55 | 54 | $4K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 31 | 30 | $4K |
| 83605 | 785 | 693 | $4K | |
| 72100 | 225 | 220 | $4K | |
| 73630 | 402 | 393 | $4K | |
| 73030 | 290 | 281 | $4K | |
| 83540 | 491 | 486 | $4K | |
| 84100 | 791 | 706 | $4K | |
| 87186 | 485 | 465 | $4K | |
| 86592 | 920 | 907 | $3K | |
| 73130 | 303 | 301 | $3K | |
| 88313 | 117 | 109 | $3K | |
| 82950 | 444 | 442 | $3K | |
| 82043 | 414 | 408 | $3K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 420 | 411 | $3K |
| 85384 | 276 | 255 | $2K | |
| 82248 | 366 | 266 | $2K | |
| 73502 | 147 | 139 | $2K | |
| 87081 | 439 | 436 | $2K | |
| 87070 | 343 | 336 | $2K | |
| 86780 | 146 | 143 | $2K | |
| 0225U | 35 | 35 | $2K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 1,144 | 999 | $2K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 51 | 51 | $2K |
| 82570 | 352 | 343 | $2K | |
| 81003 | 729 | 698 | $2K | |
| 82105 | 102 | 101 | $2K | |
| 90715 | 130 | 130 | $2K | |
| 84153 | 89 | 86 | $2K | |
| 82746 | 174 | 174 | $2K | |
| 12001 | 83 | 83 | $2K | |
| 59025 | Fetal non-stress test | 239 | 165 | $2K |
| 84550 | 325 | 299 | $2K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 39 | 39 | $2K |
| 83655 | 151 | 149 | $2K | |
| 86480 | 19 | 19 | $1K | |
| 82805 | 58 | 57 | $1K | |
| 82550 | 257 | 253 | $1K | |
| 12011 | 30 | 29 | $1K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 15 | 14 | $1K |
| 87147 | 341 | 325 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 2,354 | 2,184 | $1K |
| 86038 | 88 | 85 | $1K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 46 | 43 | $1K |
| 85652 | 422 | 408 | $1K | |
| 70486 | 13 | 13 | $1K | |
| 84146 | 50 | 49 | $1K | |
| 86140 | 392 | 374 | $1K | |
| 82962 | 842 | 525 | $1K | |
| 86618 | 46 | 45 | $1K | |
| 77065 | Tomosynthesis, mammo | 16 | 15 | $983.04 |
| 87486 | 51 | 49 | $965.18 | |
| 83615 | 149 | 142 | $944.82 | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 25 | 24 | $934.63 |
| 82951 | 72 | 72 | $931.52 | |
| 73110 | 94 | 92 | $916.08 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 53 | 51 | $841.42 |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 51 | 47 | $828.81 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 99 | 91 | $814.05 |
| G0475 | Hiv antigen/antibody, combination assay, screening | 28 | 27 | $786.60 |
| 85018 | 289 | 283 | $753.09 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 541 | 438 | $692.10 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 539 | 509 | $682.06 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,022 | 965 | $680.88 |
| 80074 | 12 | 12 | $610.83 | |
| J2704 | Injection, propofol, 10 mg | 1,305 | 1,134 | $609.19 |
| 85014 | 205 | 203 | $593.90 | |
| 84145 | 28 | 28 | $567.45 | |
| T1015 | Clinic visit/encounter, all-inclusive | 14 | 13 | $554.00 |
| 86787 | 31 | 30 | $553.88 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 79 | 78 | $553.50 |
| 83021 | 26 | 26 | $500.17 | |
| 82077 | 160 | 139 | $458.64 | |
| 72040 | 30 | 29 | $424.52 | |
| 73590 | 27 | 26 | $383.01 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 1,963 | 1,812 | $378.06 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 679 | 643 | $375.31 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 755 | 703 | $360.36 |
| 87209 | 16 | 16 | $327.44 | |
| 86317 | 15 | 15 | $295.45 | |
| 84156 | 92 | 89 | $287.22 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,047 | 993 | $236.49 |
| 86704 | 15 | 15 | $217.06 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 338 | 295 | $214.71 |
| 84460 | 28 | 28 | $206.57 | |
| 80069 | 55 | 48 | $201.16 | |
| 80076 | 24 | 24 | $199.83 | |
| 80179 | 65 | 55 | $191.52 | |
| 80143 | 68 | 57 | $191.52 | |
| 86430 | 27 | 27 | $191.46 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 926 | 850 | $185.13 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 61 | 57 | $183.68 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 173 | 152 | $182.23 |
| 82150 | 40 | 40 | $166.19 | |
| 82247 | 22 | 13 | $159.08 | |
| 82952 | 46 | 46 | $157.83 | |
| J2060 | Injection, lorazepam, 2 mg | 210 | 183 | $142.53 |
| 86769 | 13 | 13 | $135.04 | |
| 73080 | 12 | 12 | $121.95 | |
| 84450 | 15 | 15 | $105.13 | |
| A9576 | Injection, gadoteridol, (prohance multipack), per ml | 78 | 74 | $104.34 |
| 85007 | 33 | 30 | $99.98 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 93 | 80 | $84.73 |
| 87177 | 14 | 14 | $61.52 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 160 | 152 | $57.88 |
| 82565 | 13 | 13 | $54.69 | |
| 85041 | 13 | 13 | $42.00 | |
| 87205 | 12 | 12 | $37.15 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 968 | 851 | $33.59 |
| 97161 | 23 | 18 | $19.77 | |
| 97165 | 23 | 18 | $15.12 | |
| 97116 | 35 | 15 | $10.46 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 502 | 468 | $8.83 |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 20 | 12 | $5.39 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 17 | 12 | $4.83 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 17 | 13 | $0.00 |
| 97535 | Self-care/home management training, each 15 minutes | 26 | 12 | $0.00 |